Carbon-bound exogenous
compounds, such as polycyclic
aromatic hydrocarbons
(PAHs), tobacco-specific nitrosamines, aromatic amines, and organohalogens,
are known to affect both tumor characteristics and patient outcomes
in lung squamous cell carcinoma (LUSC); however, the roles of these
compounds in lung adenocarcinoma (LUAD) remain unclear. We analyzed
11 carbon-bound exogenous compounds in LUAD and LUSC samples using
in situ high mass-resolution matrix-assisted laser desorption/ionization
Fourier-transform ion cyclotron resonance mass spectrometry imaging
and performed a cluster analysis to compare the patterns of carbon-bound
exogenous compounds between these two lung cancer subtypes. Correlation
analyses were conducted to investigate associations among exogenous
compounds, endogenous metabolites, and clinical data, including patient
survival outcomes and smoking behaviors. Additionally, we examined
differences in exogenous compound patterns between normal and tumor
tissues. Our analyses revealed that PAHs, aromatic amines, and organohalogens
were more abundant in LUAD than in LUSC, whereas the tobacco-specific
nitrosamine nicotine-derived nitrosamine ketone was more abundant
in LUSC. Patients with LUAD and LUSC could be separated according
to carbon-bound exogenous compound patterns detected in the tumor
compartment. The same compounds had differential impacts on patient
outcomes, depending on the cancer subtype. Correlation and network
analyses indicated substantial differences between LUAD and LUSC metabolomes,
associated with substantial differences in the patterns of the carbon-bound
exogenous compounds. These data suggest that the contributions of
these carcinogenic compounds to cancer biology may differ according
to the cancer subtypes.